European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology

Abstract

The current guidelines represent consensual expert opinions and definitions on the use of IVIg reflecting current published evidence and are intended to serve as a decision-making tool for the use of IVIg in dermatological diseases.